Theravance Biopharma Financial Overview
Theravance Biopharma's market cap is currently $902.48M. The company's EPS TTM is $0.07; its P/E ratio is 31.31; Theravance Biopharma is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $1.00. See an overview of income statement, balance sheet, and cash flow financials.
